Pharmaceutical and medicine manufacturing R&D funded by foreign companies
RecordSTO-MM257ZMAAR-EGBJJTTF3T-73T6R0
United States · 2023
Pharmaceutical and medicine manufacturing R&D funded by foreign companies in the United States was 9 billion USD in 2023 (NCSES).
Pharmaceutical R&D investment in United States: every year, the rank and how it is measured
- Publisher
- NCSES
- Authority tier
- T1 Official
- Locator
- R&D Performance, by Type of R&D, Industry Sector, and Source of Funding
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Sixty-six percent of foreign company R&D funding went to three industry groups: pharmaceuticals and medicines (NAICS 3254) ($9 billion), scientific research and development services (NAICS 5417) ($4 billion), and computer and electronic products (NAICS 334) ($4 billion) (table 2).
Checked: the figure 9 billion USDis stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0
Other formats: MLA, Chicago, BibTeX
- MLA
- National Center for Science and Engineering Statistics. "Business R&D Performance in the United States Increases to $722 Billion in 2023." 2023, https://ncses.nsf.gov/pubs/nsf25353. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0.
- Chicago
- National Center for Science and Engineering Statistics. "Business R&D Performance in the United States Increases to $722 Billion in 2023." 2023. https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0.
- BibTeX
- @misc{ncses2023pharmaceutical73t6r0, author = {{National Center for Science and Engineering Statistics}}, title = {Business R\&D Performance in the United States Increases to \$722 Billion in 2023}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0}, note = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Center for Science and Engineering Statistics · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Business R&D Performance in the United States Increases to $722 Billion in 2023
- Type
- Press release
- Published
- —
- Locator
- R&D Performance, by Type of R&D, Industry Sector, and Source of Funding
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_MM257ZMAAREGBJJTTF3T73T6R0